Skip to main content

Table 2 AUC0–12 change from day 1

From: The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD

Parameter BDP/F/G BDP/F BDP/F/G – BDP/F
Mean difference p value
FVC (mls) 545
(414, 676)
339
(208, 470)
206
(54, 359)
0.0116
FEF25–75% (L/s) 0.110
(0.077, 0.143)
0.083
(0.050, 0.117)
0.026
(0.001, 0.051)
0.0395
sGaw (L/s/kPa/L) 0.311
(0.242, 0.381)
0.213
(0.143, 0.282)
0.099
(0.031, 0.167)
0.0101
Raw (kPa/L/s)  − 0.279
(− 0.323, − 0.236)
 − 0.222
(− 0.266, − 0.179)
 − 0.057
(− 0.077, − 0.037)
 < 0.0001
IC (mls) 257
(135, 379)
260
(138, 382)
3
(− 146, 139)
0.96
FRC (mls)  − 490
(− 632, − 348)
 − 387
(− 529, − 245)
 − 103
(− 217, 11)
0.07
TLC (mls)  − 218
(− 319, − 117)
 − 137
(− 238, − 36)
 − 81
(− 196, 34)
0.16
R5–R20 (kPa/L/s)  − 0.163
(− 0.195, − 0.131)
 − 0.118
(− 0.150, − 0.086)
 − 0.045
(− 0.065, − 0.025)
0.0002
X5 (kPa/L/s) 0.203
(0.155, 0.252)
0.156
(0.108, 0.205)
0.047
(0.025, 0.069)
0.0003
∆X5 (kPa/L/s)  − 0.137
(− 0.219, − 0.056)
 − 0.095
(− 0.177, − 0.014)
 − 0.042
(− 0.086, 0.002)
0.06
Fres (1/s)  − 7.201
(− 9.091, − 5.310)
 − 5.005
(− 6.896, − 3.115)
 − 2.195
(− 3.451, − 0.940)
0.0016
AX (kPa/L)  − 2.911
(− 3.467, − 2.356)
 − 2.205
(− 2.761, − 1.650),
 − 0.706
(− 1.047, − 0.365)
0.0004
  1. Data = mean (95% CI) change in day 5 AUC0–12 from day 1. Treatment difference = BDP/F/G (AUC0–12 change at day 5 from day 1) – BDP/F (AUC0–12 change at day 5 from day 1)